In anesthetized BALB/c mice ventilated at constant tidal volume (8 ml/kg), mean AFC rate was 12.8% at 6 cmH 2O P, but increased to 37.3% at 18 cmH 2O P. AFC rate declined at 22 cmH2O P, which also induced lung damage. Increased AFC at 18 cmH 2O P did not result from elevated plasma catecholamines, hypercapnia, or hypocapnia, but was due to augmented Na ϩ and Cl Ϫ absorption. PKA agonists and ␤-agonists stimulated AFC at 10 cmH 2O P by upregulating amiloride-sensitive Na ϩ transport. However, at 18 cmH2O P, PKA agonists and ␤-agonists reduced AFC. At 15 cmH 2O P, the AFC rate was intermediate (mean 26.6%), and forskolin and ␤-agonists had no effect. Comparable P dependency of AFC and ␤-agonist responsiveness was found in C57BL/6 mice. The effect on AFC of increasing P to 18 cmH 2O was blocked by adenosine deaminase or an A 2b-adenosine receptor antagonist, and could be mimicked by adenosine in mice ventilated at 10 cmH 2O P. Modulation of adenosine signaling also resulted in altered responsiveness to ␤-agonists. These findings indicate that, in the normal mouse lung, basal AFC rates and responses to ␤-agonists are impacted by ventilation pressure in an adenosine-dependent manner. tidal volume; epithelial sodium channel; adenosine ACUTE LUNG INJURY (ALI) and the acute respiratory distress syndrome (ARDS) remain important causes of morbidity and mortality in the intensive care unit, which are usually treated with a combination of mechanical ventilation, diuresis, and management of the underlying cause (2). Even in the best of circumstances, ARDS mortality rates above 30% are the norm, and efforts to improve outcomes are ongoing. Recently, the ARMA trial conclusively demonstrated that reducing tidal volume (V T ) during positive-pressure mechanical ventilation lowers mortality in patients with ALI and ARDS (40). However, the effects of modulating ventilation pressure (P) on survival are less well defined (17).
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The epithelial surface of the lung is normally covered with a thin layer of fluid. The ability of the bronchoalveolar epithelium to actively transport sodium (Na ϩ ) ions from the alveolar lining to the interstitium provides a motive force for clearance of excess air space fluid from the lungs (7) . This process of alveolar fluid clearance (AFC), which is crucial to maintenance of efficient gas exchange in the normal lung, is also important in ALI and ARDS: in a pioneering and elegant study, Ware and Matthay (43) clearly demonstrated that patients with ALI/ ARDS with intact AFC have lower morbidity and mortality than those with compromised AFC. Interestingly, high V T has been shown to be detrimental to AFC in ventilated rats (14) , inhibiting both cAMP-dependent AFC (15) and Na ϩ -K ϩ -ATPase activity (1) : it is possible that this observation may account for some of the clinical benefit of lower V T reported in the ARMA trial.
AFC rate can be modulated by a variety of factors, including hypoxia, hyperoxia, hypocapnia, hypercapnia, viral or bacterial infection, and presence of proinflammatory mediators (25) . Both exogenous and endogenous ␤-agonists can improve AFC in animal models of ALI in which AFC is impaired by increasing the activity of both epithelial Na ϩ channels (ENaC) and the Na ϩ -K ϩ -ATPase (27) . Intravenous or aerosolized salbutamol treatment has also been shown to reduce extravascular lung water in, respectively, patients with ALI (33) and those who have undergone lung resection (24) . However, the effects of P on AFC responses to ␤-agonists (if any) have not been determined. Moreover, P values have not been standardized between most studies on AFC in mice. Herein, we demonstrate that, in mice ventilated at constant low V T , P influences both basal AFC rates and AFC responses to ␤-agonists. Increasing P significantly raises the basal AFC rate in an adenosine-dependent manner. However, ␤-agonists have no effect on AFC in mice ventilated with intermediate P unless A 2b -subtype adenosine receptor (AdoR) activation is blocked and reduce AFC when mice are ventilated with high P.
MATERIALS AND METHODS
Reagents. Except where noted, all reagents were from SigmaAldrich (St. Louis, MO). Amiloride, CFTR inh-172 (EMD Biosciences, La Jolla, CA), forskolin, cholera toxin, propranolol, glibenclamide, DPCPX (8-cyclopentyl-1,3-dipropylxanthine; Tocris Bioscience, Ellisville, MO), and ZM241385 (4-(2-[7-Amino-2-(2-furyl) [1, 2, 4] triazolo [2,3-a] [1, 3, 5] triazin-5-ylamino]ethyl)phenol; Tocris) were reconstituted in DMSO. 14 -22 amide (EMD Biosciences), MRS 1754 [N-(4-cyanophenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl) phenoxy]-acetamide; Tocris], and all other reagents were reconstituted in normal saline. Fresh terbutaline stocks were prepared weekly. All reagents were added to the AFC instillate from stock solutions directly before instillation into mice, in a minimal volume of solvent (1-5 l/ml). Final working concentrations of each reagent (as reported in the text) were based on previously published studies by other groups, when available. This was the case for amiloride (13, 18) , forskolin (18, 41) , terbutaline (13) , propranolol (13, 16) , glibenclamide (13) , and adenosine (12) . CFTR inh-172 has been used at 1 M concentration in some prior studies (12) . However, in our hands, CFTR inh-172 was ineffective at doses below 10 M, and data were most consistent (had lower variance) using 100 M CFTR inh-172. This agent was therefore used at 100 M concentration in the current report, as in our previous studies (44) .
AFC measurements. AFC was measured in 8-to 12-wk-old pathogen-free mice of either sex, as previously described (9) . Briefly, mice were anesthetized with valium (5 mg/kg) followed by ketamine (200 mg/kg) 6 min later and tracheotomized, and a trimmed sterile 18-g intravenous catheter was inserted caudally into the tracheal lumen. Isoflurane was not used in our studies as it has been shown to depress AFC in rats (36) . Following administration of pancuronium (0.08 g/kg ip), each mouse was placed on a Deltaphase isothermal heating pad (Braintree Scientific, Braintree, MA) and ventilated on a model 687 volume-controlled mouse ventilator (Harvard Apparatus, Holliston, MA) with a 200-l VT (8 ml/kg body wt), on 100% O2, at 160 breaths/min. Once the mouse was stable on the ventilator, it was briefly disconnected to permit instillation of 300 l of 5% BSA/saline (322 mOsm/l, isosmotic to mouse plasma) into the dependent (left) lung via the tracheal cannula, which was then flushed with 100 l of air before reconnection to the ventilator. After 30-min ventilation, instilled fluid was aspirated to measure protein content and calculate AFC rate. In all studies, four ventilators were run concurrently (with the procedure staggered by a 3-min interval). We have found no gender differences in AFC rate in BALB/c mice. All mouse procedures were approved by the Institutional Animal Care and Use Committee at The Ohio State University.
Measurement of bronchoalveolar epithelial permeability. AFC procedures were performed using a 5% BSA solution containing 0.16 mg/ml FITC-albumin (Sigma-Aldrich), as previously described (44) . The amount of FITC-albumin detectable in peripheral serum at the end of the AFC procedure was measured at 520 nm (excitation 487 nm) in a NanoDrop 1000 fluorescence spectrometer (Thermo Scientific, Wilmington, DE) (37) .
Modulation and measurement of P. For constant-volume ventilation studies, 1.5 l/min fresh 100% O2 was delivered to the model 687 volume-controlled mouse ventilator from a compressed gas cylinder, via a step-down regulator (SurgiVet; Smiths Medical, Waukesha, WI). This provided 4 cmH2O gas pressure (GP) to the ventilator. To modulate P (while maintaining constant V T), an adjustable tube clamp (Harvard Apparatus) was applied to a 3Љ length of Tygon R-3603 tubing (Harvard Apparatus) attached to the ventilator exhaust port. Variably tightening the tube clamp allowed us to deliver 2-18 cmH2O PEEP to the expiratory limb of the circuit, for a final ventilator pressure range of 6 -22 cmH 2O (GP ϩ PEEP). Final mean pressure (P) was measured at the Y-tube, to which the tracheal cannula is ordinarily attached when mice are ventilated, with a U-tube manometer (Scireq, Montreal, Quebec).
To confirm findings with this system, effects of P on AFC were measured using a pressure-controlled ventilator, in which P is determined by the PEEP level generated with a water-bottle PEEP trap. For these studies, mice were ventilated for a 30-min period on a TOPO pressure-controlled small animal ventilator (Kent Scientific, Torrington, CT) using 100% O2 at 160 breaths/min and 220 l VT. The AFC procedure was performed as described above.
Measurement of end-tidal PCO2. End-tidal PCO2 was measured at the end of a 30-min ventilation period in the absence of AFC instillate using a microCapStar end-tidal CO2 monitor for mice (CWE, Ardmore, PA).
Preparation of lung homogenates. Following ventilation for 30 min (in the absence of instillate fluid), lung lobes were dissected free of airways and homogenized in 1 ml of sterile saline using a Glas-Col variable speed reversible homogenizer (Daigger Lab Equipment, Vernon Hills, IL) with a 2-ml glass tube and pestle. Homogenates were centrifuged for 10 min at 1,000 rpm to remove debris and then frozen at Ϫ80°C for later analysis.
Measurement of bronchoalveolar lavage and lung homogenate mediators. Cytokines and chemokines were measured using an ultrasensitive mouse proinflammatory multiplex electrochemiluminescence assay kit (Meso Scale Discovery, Gaithersburg, MD). Total nitrate/nitrite was measured using a fluorometric assay kit (Cayman Chemical, Ann Arbor, MI). Lactate dehydrogenase (LDH) was measured with a colorimetric assay (Cayman Chemical). All assays were performed in accordance with the manufacturer's instructions.
Other methods. All other methods were performed as previously described (9) .
Statistical analyses. Descriptive statistics were calculated using Instat software (GraphPad). Gaussian data distribution was verified by the method of Kolmogorov and Smirnov. Differences between group means were analyzed by ANOVA, with Tukey-Kramer multiple comparison posttests. Correlations were calculated by Pearson linear correlation analysis. P Ͻ 0.05 was considered statistically significant. All data are presented as means Ϯ SE.
RESULTS

Effect of P on basal AFC rate in BALB/c mice.
To perform studies investigating the effects of P on AFC, we modified a standard small rodent ventilator circuit so that the final mean pressure delivered to the tracheal cannula could be varied simply by adjusting a clamp on the ventilator exhaust port. This modification allowed us to modulate P while maintaining a constant 200-l V T and ventilation rate.
We found that, in mice ventilated at constant, low V T (8 ml/kg), modulating P had a significant effect on basal AFC rate (with only 5% BSA/saline in the AFC instillate; Fig. 1A ). With very low (6 cmH 2 O) or low (10 cmH 2 O) mean P, basal AFC rates were significantly lower than in our previous studies (6, 8) in which we should note that P was never measured. In contrast, when mean P was raised to 18 cmH 2 O, the basal AFC rate was significantly increased (P Ͻ 0.0005) and was identical to that which we previously reported in both C57BL/6 and BALB/c mice (9, 19, 20) (a finding that suggests that P in these earlier studies was ϳ18 cmH 2 O). Increasing P further to 22 cmH 2 O on the volume-regulated ventilator did not result in an additional increase in AFC, but rather significantly decreased AFC (P Ͻ 0.05) from its rate at 18 cmH 2 O. Ventilation with intermediate mean P (15 cmH 2 O) resulted in an intermediate AFC value, significantly different from AFC rates at both low and high P (both P Ͻ 0.0005). Raising P from 10 cmH 2 O to 18 cmH 2 O after 15 min had a comparable effect to ventilation for 30 min with 15 cmH 2 O P. When mice were ventilated at 4 cmH 2 O P (GP ϩ 0 cmH 2 O PEEP), all animals rapidly died (in 5 min or less) from hypoxemia and subsequent cardiac stasis, and AFC was therefore not measurable. Finally, there was a highly significant correlation (P Ͻ 0.0005) between P and basal AFC rate in mice ventilated with a constant mean P of between 6 and 18 cmH 2 O for 30 min (r 2 ϭ 0.74). Because these data were generated by modifying outflow resistance in a standard volume-controlled ventilator, the effects of P on AFC were also investigated using a pressurecontrolled ventilator, in which P could be controlled in a more orthodox fashion by modulating PEEP. Despite the slightly higher V T generated with this system (ϳ9 ml/kg), an identical effect of P on AFC was elicited (Fig. 1B) . These data confirm that the observed AFC effect is dependent on P regardless of its method of generation.
The epithelial Na ϩ channel inhibitor amiloride (1.5 mM) reduced AFC to an identical point in mice ventilated with both 10 and 18 cmH 2 O P (Fig. 1C) . Mean amiloride-insensitive AFC was 10.9 Ϯ 1.1% in mice ventilated with 10 cmH 2 O P, compared with 11.5 Ϯ 0.6% in mice ventilated with 18 cmH 2 O P. This finding indicates that the higher basal AFC rate at 18 cmH 2 O P is a consequence of increased amiloride-sensitive AFC (Na ϩ absorption). Indeed, the amiloride-sensitive fraction of total AFC was significantly greater at 18 cmH 2 O P (69%) than at 10 cmH 2 O P (39%). The CFTR Cl Ϫ channel inhibitors glibenclamide and CFTR inh -172 (both 100 M) significantly reduced AFC in mice ventilated with 18 cmH 2 O P (to a similar degree), but had no effect on AFC rate in mice ventilated with 10 cmH 2 O P (Fig. 1C) . This finding indicates that the higher basal AFC rate at 18 cmH 2 O P is also a consequence of upregulated CFTR inh -172-sensitive AFC (Cl Ϫ absorption via CFTR).
␤-agonists have been shown to increase AFC in normal and injured lungs (27) , whereas both hypercapnia (PCO 2 of 60 mmHg) (3) and hypocapnia (PCO 2 Յ 20 mmHg) (30) have been shown to inhibit AFC. However, increasing P from 10 to 18 cmH 2 O had no effect on either plasma epinephrine levels (63 Ϯ 3 pg/ml and 60 Ϯ 2 pg/ml, respectively; n ϭ 8) or plasma norepinephrine levels (810 Ϯ 71 pg/ml and 840 Ϯ 48 pg/ml, respectively; n ϭ 8), which were measured at the end of the 30-min ventilation period, and which did not differ significantly from those in unventilated mice. Moreover, there was no evidence of hypocapnia, hypercapnia (end-tidal PCO 2 Ͼ 40 mmHg), or alteration of bronchoalveolar lavage (BAL) fluid pH between mice ventilated with 10 cmH 2 O P (pH ϭ 7.0 Ϯ 0.1; n ϭ 7) and those ventilated with 18 cmH 2 O P (pH ϭ 6.9 Ϯ 0.1; n ϭ 9).
Effect of P on proinflammatory mediators and indices of lung damage in normal BALB/c mice. No differences in lung water content, BAL protein levels, BAL LDH levels, or amount of FITC-conjugated BSA translocating from the AFC instillate to the bloodstream over a 30-min period were found between animals ventilated with 10 or 18 cmH 2 O P (Table 1) . Moreover, lung tissue sections from mice ventilated with both low and high P exhibited normal histoarchitecture, with no evidence of inflammation, hemorrhage, or tissue damage (data not shown). Likewise, no differences in lung homogenate proinflammatory cytokine/chemokine content (which was low, with KC and IL-1␤ present in the highest quantities at 90 -130 pg/ml) or BAL nitrate/nitrite levels (21-22 M) were noted between mice ventilated with 10 and 18 cmH 2 O P.
Together, these findings demonstrate that ventilation with 18 cmH 2 O P does not induce significantly more lung inflammation or damage than ventilation with 10 cmH 2 O P.
In contrast, ventilation with very high P (22 cmH 2 O) resulted in significant increases in lung water content, BAL protein levels, BAL LDH levels, and FITC-conjugated BSA translocation from the AFC instillate to the bloodstream (Table  1 ). These data indicate that ventilation with very high P causes significant lung damage, which might account for the observed reduction in AFC rate observed at this P level.
Effect of P on AFC response to activators of PKA. In agreement with previous studies (27) , the plant toxin forskolin (50 M), which directly activates adenylyl cyclase, significantly stimulated AFC when normal BALB/c mice were ventilated with 10 cmH 2 O P ( Fig. 2A) . This effect was completely blocked by the PKA inhibitor 14 -22 amide (1 g/ml) and by amiloride (1.5 mM). In contrast, forskolin (50 M) significantly inhibited AFC in normal BALB/c mice ventilated with 18 cmH 2 O P. AFC rates were in fact comparable between forskolin-treated mice ventilated at 10 or 18 cmH 2 O P. Again, the effect of forskolin in mice ventilated at 18 cmH 2 O P could be completely blocked by the PKA inhibitor 14 -22 amide (1 g/ml). However, while decreasing overall AFC rate, forskolin significantly increased amiloride-insensitive AFC (P Ͻ 0.005) in mice ventilated at 18 cmH 2 O P. This may reflect activation by cAMP of either amiloride-insensitive Na ϩ channels or the Na ϩ -K ϩ -ATPase, as has been previously described (5). To confirm the specificity of the observed forskolin effects, we examined the effects of cholera toxin (1 g/ml), which ADP-ribosylates and thereby constitutively activates the stimulatory ␣-subunits of heterotrimeric G proteins. Cholera toxin had a greater stimulatory effect on AFC than that of forskolin in normal mice ventilated at 10 cmH 2 O P and a greater inhibitory effect on AFC than that of forskolin in mice ventilated at 18 cmH 2 O P (Fig. 2B) . Finally, the effect of forskolin was replicated by the stable cAMP analog 8-Br-cAMP (50 M), which stimulated AFC significantly at low P and inhibited AFC at high P, so that final AFC rates were almost identical in both groups.
When mice were ventilated with 15 cmH 2 O P, forskolin had no detectable effect on basal AFC rate: 50 M forskolin increased AFC by only 1.4% at intermediate P (n ϭ 7).
There are significant differences in lung structure and mechanics between inbred mouse strains (38) . In particular, alveolar size can vary greatly between strains with comparable total lung capacity (39) . However, the effects of forskolin on AFC in mice ventilated at either high or low P were not strain dependent. Ventilation of normal C57BL/6 mice at 10 cmH 2 O P had a greater suppressive effect on basal AFC rate than in BALB/c mice. Mean AFC rate was 12.9 Ϯ 1.8% (n ϭ 7) compared with 18.0 Ϯ 0.8% in the BALB/c strain. However, under these conditions, 50 M forskolin stimulated AFC significantly (by 66%, n ϭ 7). When C57BL/6 mice were ventilated at 18 cmH 2 O P, basal AFC rate was comparable to that in BALB/c mice (36.9 Ϯ 1.8%; n ϭ 7), and 50 M forskolin inhibited AFC to an identical extent (36%) to its effect in BALB/c mice (n ϭ 7).
Effect of P on AFC responses to ␤-adrenergic agonists in BALB/c mice. The ␤-agonist terbutaline (100 M) had a comparable stimulatory effect on AFC to forskolin when mice were ventilated with 10 cmH 2 O P (Fig. 3A) . This increase in AFC could be completely inhibited by the nonspecific ␤-blocker propranolol (100 M) or the PKA inhibitor 14 -22 amide (1 g/ml). In contrast, when mice were ventilated with 18 cmH 2 O P, terbutaline decreased AFC. As after forskolin treatment, AFC rates were comparable between terbutalinetreated mice ventilated at low or high P. The inhibitory effect of terbutaline on AFC at 18 cmH 2 O P could be blocked by propranolol (100 M), but was not affected by the ␤ 1 -adrenergic receptor (AR) blocker atenolol (100 M).
The stimulatory effects of terbutaline on AFC at 10 cmH 2 O P were blocked by amiloride (1.5 mM) and the CFTR anion channel inhibitors glibenclamide and CFTR inh -172 (both 100 M) (Fig. 3B) . Like forskolin, terbutaline significantly increased amiloride-insensitive AFC (P Ͻ 0.005) in mice ventilated at 18 cmH 2 O P. However, the AFC decrease induced by terbutaline at 18 cmH 2 O P was unaffected by glibenclamide or CFTR inh -172. Finally, comparable or greater inhibitory effects on AFC to that of terbutaline (35% inhibition) were induced by salmeterol (a highly potent, long-acting ␤ 2 -AR agonist, 39% inhibition), isoproterenol (a nonspecific ␤-agonist, 49% inhibition), and procaterol (a short-acting ␤ 2 -AR agonist, 70% inhibition) in mice ventilated with 18 cmH 2 O P (n ϭ 6 -10 per group).
When mice were ventilated with 15 cmH 2 O P, terbutaline had no detectable effect on basal AFC rate: 100 M terbutaline decreased AFC by only 2.2% (n ϭ 19). The AFC rate at 15 cmH 2 O P (27%) therefore effectively represents the inflection point for the transition from stimulatory to inhibitory effects of terbutaline on AFC. Indeed, there was a significant correlation between mean basal AFC rate (which is dependent on P) and mean % change in AFC in response to 100 M terbutaline (P Ͻ 0.05, r 2 ϭ 0.997, n ϭ 3). Role of adenosine in mediating stimulatory effect of P on AFC in BALB/c mice. Eckle et al. (10) recently demonstrated that stimulation of A 2b -subtype AdoR can increase AFC in C57BL/6 mice. We found that 100 M adenosine had a very significant stimulatory effect on AFC in BALB/c mice ventilated at 10 cmH 2 O P and effectively raised AFC rate in these animals to that seen in untreated mice ventilated at 18 cmH 2 O P (Fig. 4A) . This stimulatory effect of adenosine could be completely blocked by the PKA inhibitor 14 -22 amide (1 g/ml). In mice ventilated at 10 cmH 2 O P, addition of adenosine to the AFC instillate also induced a comparable response to terbutaline (reduced AFC) to that seen in untreated mice ventilated at 18 cmH 2 O P. Similarly, in mice ventilated at 18 cmH 2 O P, the increase in AFC rate over animals ventilated at 10 cmH 2 O P was completely blocked by adenosine deaminase (2 U/ml). Moreover, under these conditions, 100 M terbutaline significantly increased AFC, mimicking its stimulatory effect on AFC in untreated mice ventilated at 10 cmH 2 O P. Finally, the increase in AFC rate induced by adenosine in mice ventilated at 10 cmH 2 O P was completely abrogated by addition of amiloride or CFTR inh -172 to the AFC instillate (Fig.  4B ). This finding indicates that, like ventilation at 18 cmH 2 O P, adenosine stimulates both increased amiloride-sensitive AFC (Na ϩ absorption) and upregulated CFTR inh -172-sensitive AFC (Cl Ϫ absorption via CFTR). A similar inhibitory effect on AFC to that of adenosine deaminase was induced in mice ventilated at 18 cmH 2 O P by an A 2b -subtype AdoR antagonist, MRS 1754 (Fig. 4C) . In contrast, AFC at 18 cmH 2 O P was unaffected by either an A 1 -subtype AdoR antagonist, DPCPX, or an A 2a -subtype receptor antagonist, ZM241385 (both 100 M). These data suggest that increased AFC at higher P may result from activation of A 2b -AdoR, possibly triggered by increased adenosine release into the alveolar lining fluid in response to alveolar stretch (11) .
Interestingly, AdoR blockade also modulated responsiveness to cAMP agonists in mice ventilated at 15 cmH 2 O P, which are normally unresponsive to either forskolin or terbutaline. While addition of 100 M MRS 1754 to the AFC instillate had no effect on AFC rate in mice ventilated at 15 cmH 2 O P (mean AFC rate was 26.6 Ϯ 1.7% in untreated mice ventilated with 15 cmH 2 O P compared with 27.3 Ϯ 2.6% in MRS 1754-treated mice), in the presence of this A 2b -AdoR antagonist, both forskolin and terbutaline significantly increased AFC (by 31%, P Ͻ 0.05, n ϭ 9, and by 43%, P Ͻ 0.0005, n ϭ 11, respectively). This finding suggests that A 2b -AdoR activation by adenosine (which appears to be a function of P) may determine the relative AFC response to cAMP agonists. , and terbutaline ϩ 1 g/ml 14 -22 amide (gray bar, 10 cmH2O P) or terbutaline ϩ 100 M atenolol (gray bar, 18 cmH2O P) on AFC in BALB/c mice ventilated with mean P of 10 cmH2O (n ϭ 7-10 per group) or 18 cmH2O (n ϭ 8 -12 per group). B: effect of 100 M terbutaline (open bars), terbutaline ϩ 1.5 mM amiloride (hatched bars), terbutaline ϩ 100 M glibenclamide (dark gray bars), and terbutaline ϩ 100 M CFTRinh-172 (light gray bars) on AFC in BALB/c mice ventilated with mean P of 10 or 18 cmH2O (n ϭ 8 -12 per group). #P Ͻ 0.0005 compared with untreated mice (closed bars) at the same mean P level.
DISCUSSION
In the current study, we found that P had a significant impact on AFC in mice ventilated at low, but constant, V T (8 ml/kg). Low P levels were detrimental to AFC rate or even lethal, whereas moderately high P levels enhanced AFC. This finding may explain unresolved discrepancies in the experimental AFC literature for mice. In our previous studies using normal C57BL/6 and BALB/c mice undergoing constant-V T ventilation with the same protocol as that used in the current study, we consistently noted basal 30-min AFC rates of 35-37% (9, 19, 20) . These AFC rates were higher than those reported by other investigators using essentially the same experimental model [e.g., 14% (28), 28% (23), 30% (16) , and 32% (29)], but the reason for this discrepancy has been unclear. Mutlu et al. (26) proposed that differences in AFC rate between experimenters may have resulted from differences between animals ventilated in dorsal and lateral recumbency, but our current data from mice uniformly ventilated in lateral recumbency do not support that hypothesis. Rather, they suggest that discrepancies in AFC rate may arise from differences in P level between mouse AFC systems in different laboratories. These may arise from variations in oxygen regulators, anesthesia circuits, and gas tubing (length, diameter, or hysteresivity), which are not compensated for by the volume-regulated ventilators generally used in these studies. Nevertheless, our results in no way invalidate those of earlier studies in which basal AFC rates were lower. For example, Fukuda et al. (16) reported a basal AFC rate of 30% over 30 min in mice ventilated at a peak airway pressure of 8 -12 cmH 2 O, with 2-3 cmH 2 O P. The current study would predict an AFC rate of 28.8% using this regimen. It is merely unfortunate that, since we were unaware of the modulatory effect of P on AFC, P was not measured when the procedure was first developed and was not therefore standardized across laboratories.
Cyclical mechanical stretch has been shown to induce release of both proinflammatory chemokines [particularly IL-8 (42)] and adenosine from human and murine lung epithelial cells. Indeed, BAL adenosine levels were increased threefold following 1 h of ventilation at 15 cmH 2 O pressure (11). Importantly, adenosine has also been shown to act as an important regulator of the balance between fluid secretion and absorption in the bronchoalveolar space (12, 22) , to partially mediate AFC impairment in influenza-infected BALB/c mice (44) , and to contribute to pulmonary edema formation following ischemia-reperfusion-induced lung injury (31) . Moreover, adenosine increases AFC in C57BL/6 mice undergoing ventilator-induced lung injury by stimulating A 2b -AdoR (10) . In agreement with these latter studies, we found that ventilation at 18 cmH 2 O P results in an increase in amiloride-sensitive, CFTR inh -172-sensitive AFC that can be blocked by adenosine deaminase and an A 2b -AdoR inhibitor and mimicked in mice ventilated at 10 cmH 2 O P with exogenous adenosine. Adenosine appears to be the primary mediator of AFC enhancement at high P. Potential roles for endogenous catecholamines (27) , alterations of bronchoalveolar PCO 2 (3, 30) , or atelectrauma (17) as mediators of responses to P were all excluded in our studies. While confirmation of our proposed mechanism will require further experiments in AdoR-knockout mice, the data presented herein provide further support for the concept that adenosine acts as a central regulator of lung fluid balance, as recently proposed by Factor et al. (12) and Kreindler and Shapiro (22) .
We found that PKA agonists (forskolin, cholera toxin, and 8-Br-cAMP) and ␤-agonists improve AFC in mice ventilated at low P (by stimulating amiloride-sensitive Na ϩ transport), which is in agreement with previous reports (27) . Prior studies have not reported a detrimental effect of PKA agonists or ␤-agonists on AFC, as we observed in mice ventilated at high P. However, basal AFC rates in these studies (16, 26, 28, 29) have generally been more comparable to those found at lower P levels in the current study, which are amenable to ␤-agonist stimulation. Moreover, the degree of AFC stimulation by ␤-agonists reported in prior studies is comparable to that observed in mice ventilated at low P in our experiments. The inhibitory effect of terbutaline at high P is also clearly specific. It can be prevented by a PKA inhibitor (14 -22 amide), adenosine deaminase, or a nonspecific ␤-blocker (propranolol), but not by a ␤ 1 -AR blocker (atenolol). The effect of forskolin is also evident in two genetically very different mouse strains (BALB/c and C57BL/6). Finally, the correlation between basal AFC rate and terbutaline effect is further strengthened by data from three prior studies (26, 34, 35) in which absolute values for mean basal AFC rate and mean % change in AFC in response to ␤-agonists were reported (in other similar studies, data were only reported in graphic form). These data points fall close to the regression line derived from our studies of normal mice (Fig. 5) . This suggests that responses to ␤-agonists may depend primarily on basal AFC rate. ␤-Agonists only stimulate AFC when the basal AFC rate is low (as a result of ALI, high V T ventilation, adenosine blockade, and/or low P ventilation). It is interesting to note, however, that treatment with forskolin, 8-Br-cAMP, or terbutaline resulted in essentially the same AFC rate (22-25%) regardless of P level. The underlying reason for this phenomenon remains unclear, but it may indicate the point at which absorptive and secretory ion transport processes (which move bronchoalveolar fluid in opposite directions and which can both be stimulated by cAMP) tend to reach equilibrium.
Previous studies have demonstrated that ␤-agonists can stimulate CFTR Cl Ϫ channels (21, 24) and can induce Cl Ϫ secretion across the alveolar epithelium (32). We found that CFTR inhibitors (glibenclamide and CFTR inh -172) partially blocked both the increase in AFC rate induced by terbutaline during low P ventilation and the increase caused by high P ventilation in the absence of ␤-agonist. This effect presumably reflects the requirement for Cl Ϫ absorption via CFTR for cAMP-stimulated AFC, as described by Fang et al. (13) . However, glibenclamide and CFTR inh -172 did not reverse terbutaline-mediated AFC inhibition in mice ventilated at high P. This suggests that reduced AFC following ␤-agonist administration to mice ventilated at high P is not a consequence of increased Cl Ϫ secretion. Nevertheless, treatment with adenosine deaminase restores the stimulatory effect of terbutaline on AFC, suggesting that the final AFC rate is determined by the relative activation state of both ␤ 2 -AR and AdoR signaling pathways.
Our findings may have implications beyond those regarding the necessity to maintain consistent P levels in mouse AFC studies. Data from rodent studies must be extrapolated to the ventilated human subject with some caution: as a consequence of differences in lung architecture and chest wall compliance (21) , particular values of P may not have identical or even similar effects on lung function in the two species. However, there are clear functional similarities in the AFC process between the murine and human lung that suggest varying P may also affect basal AFC rates and AFC response to ␤-agonists in human subjects (7) . Moreover, ARDS patients have traditionally been ventilated at PEEP levels from 5 to 12 cmH 2 O (17), which is comparable to the range used in the current study (6 -18 cmH 2 O). Interestingly, in a recent small clinical trial in which short-term application of PEEP was used as a recruitment maneuver in ventilated ARDS patients (4), a positive recruitment response was associated with AFC rates significantly higher than those reported by Ware and Matthay for ARDS patients (43) . Unfortunately, the mechanism underlying this effect was not defined, although our data [together with those of Eckle et al. (10, 11) ] suggest that it may be adenosine mediated. In summary, we found that in mice ventilated at constant low V T , P had a significant impact on both basal AFC rates and AFC responses to ␤-agonists. The stimulatory effect of P on AFC appears to be mediated by adenosine, which is presumably released in greater amounts in response to increased alveolar P. Our data support the proposed therapeutic usage of both ␤-agonists (25) and A 2b -AdoR agonists (10) to stimulate AFC in ALI, but also suggest that combination therapy might be detrimental to resolution of alveolar edema. However, we should note that the results of these studies with mice, while tending to confirm our hypothesis that P modulates AFC, may not be directly extrapolated to humans with ALI until they have been confirmed in larger animal models.
